The hinge region of the human papillomavirus type 8 E2 protein activates the human p21WAF1/CIP1 promoter via interaction with Sp 1

Journal of General Virology

Volumn 83, Issue 3, 2002, Pages 503-510

  Steger, Gertrud ^a   Schnabel, Carsta ^a   Schmidt, Hanns Martin ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE; PROTEIN P21; TRANSCRIPTION FACTOR SP1; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE SEQUENCE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; VIRUS GENE; VIRUS STRAIN; VIRUS TRANSCRIPTION; WART VIRUS;

ANIMALIA; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 8; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0036187715     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-3-503     Document Type: Article

References (38)

1. Oct-2 facilitates functional preinitiation complex assembly and is continuously required at the promoter for multiple rounds of transcription
2. Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins
3. A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2
4. Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain
5. WAF1/Cip1: More than a break to the cell cycle?
6. Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex
7. Structural and mutational analysis of E2 transactivating proteins of papillomaviruses reveal three distinct functional domains
8. Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions
9. Several different upstream promoter elements can potentiate transactivation by the BPV-1 E2 protein
10. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure
11. Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain
12. Bovine papilloma virus encoded E2 protein activates lymphokine genes through DNA elements distinct from the consensus motif, in the long control region of its own genome
13. WAF1/Cip1 gene by acting as a super activator of the ubiquitous transcription factor Sp1
14. A human papillomavirus E2 transcriptional activator
15. A transcriptional repressor encoded by BPV1 shares a common carboxy-terminal domain with the E2 transactivator
16. cAMP response element binding protein-binding protein binds to human papillomavirus E2 protein and activates E2 dependent transcription
17. A papillomavirus E2 phosphorylation mutant exhibits normal transient replication and transformation but is defective in transformation and plasmid retention
18. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome
19. Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription
20. The function of the human papillomavirus type 11 E1, E2 and E2C proteins in cell-free DNA replication
21. Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1
22. E2 polypeptides encoded by the bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: Transactivation is mediated by the conserved amino-terminal domain
23. Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB
24. Waf1/Cip1 regulation by transforming growth factor-beta
25. AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins
26. Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number
27. Cip1/WAF1 in keratinocyte differentiation
28. Malignant transformation of cutaneous lesions in renal allograft patients: A role of human papillomaviruses
29. Transactivation of a bovine papillomavirus transcriptional regulatory element by the E2 gene product
30. 2443 promoter
31. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein
32. The bovine papillomavirus 1 E2 protein contains two activation domains: One that interacts with TBP and another that functions after TBP binding
33. Low-affinity E2 binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter
34. The E8E2C protein, a negative regulator of viral transcription and replication, is required for chromosomal maintenance of human papillomavirus type 31 in keratinocytes
35. Trans activation by the full-length E2 protein of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: Cooperation with activation domains of cellular transcription factors
36. p300 collaborates with Sp1 and Sp3 in p21waf1/cip1 promoter activation induced by histone deacetylase inhibitor
37. Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB
38. The hinge of human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association